Jacobs Levy Equity Management
LCTX icon

Jacobs Levy Equity Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Jacobs Levy Equity Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$519K Buy
2023
Q1 		– Sell
2022
Q4 		$237K Sell
2022
Q3 		$291K Buy
2018
Q3 		– Sell
2018
Q2 		$214K Buy
2018
Q1 		$188K Sell
2017
Q4 		$280K Sell
2017
Q3 		$403K Buy
2017
Q2 		$362K Buy